16 December 2024
: Case report
[In Press] Post-Transplant Lymphoproliferative Disorder at the Porta Hepatis Causing Hepatic Artery Stenosis and Cholestasis
Unusual clinical course, Challenging differential diagnosis, Unusual or unexpected effect of treatment, Diagnostic / therapeutic accidents
Badi Rawashdeh1AE, Christina Papageorge2EF, Yazan Al-Adwan![ORCID logo](https://jours.isi-science.com/images/id_icon_32.png)
DOI: 10.12659/AJCR.945837
Am J Case Rep In Press; DOI: 10.12659/AJCR.945837
Available online: 2024-12-16, In Press, Corrected Proof
Publication in the "In-Press" formula aims at speeding up the public availability of the pending manuscript while waiting for the final publication. The assigned DOI number is active and citable. The availability of the article in the Medline, PubMed and PMC databases as well as Web of Science will be obtained after the final publication according to the journal schedule
Abstract
BACKGROUND
Post-transplant lymphoproliferative disorder (PTLD) encompasses a group of disorders ranging from hyperplastic to malignant lymphoid proliferations in the post-transplant period owing to immunosuppression, often in the setting of EBV transformation. PTLD is a rare complication of immunosuppression that, like lymphomas, can have a variable presentation based on disease localization. We report a case of PTLD mass effect at the porta hepatis for the first time in the literature, resulting in hepatic artery stenosis (HAS) and common hepatic duct obstruction.
CASE REPORT
A 54-year-old woman presented with cholestasis 4 months after receiving a deceased donor liver transplant. MRCP revealed a mass at the porta hepatis causing biliary compression, which resolved with subsequent biliary stenting. The woman presented again 3 weeks later with a similar presentation. CT revealed that the mass had enlarged, causing HAS, which resolved with subsequent hepatic artery stenting. The biopsy revealed PTLD, and the patient was successfully managed with rituximab and a reduction of her immunosuppressive regimen.
CONCLUSIONS
This case report describes a rare occurrence of PTLD, which particularly impacting the porta hepatis, resulting in HAS and compression of the bile duct. PTLD should be considered in the differential diagnosis for obstructive jaundice and hepatic artery compression, even in the early post-transplant months, when these symptoms are often attributed to surgical factors.
Keywords: Liver Transplantation; Lymphoma; Bile Ducts; Hepatic Artery; Stents
In Press
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.945837
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.945952
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.945718
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.946322
Most Viewed Current Articles
21 Jun 2024 : Case report
82,334
DOI :10.12659/AJCR.944371
Am J Case Rep 2024; 25:e944371
07 Mar 2024 : Case report
48,898
DOI :10.12659/AJCR.943133
Am J Case Rep 2024; 25:e943133
20 Nov 2023 : Case report
23,170
DOI :10.12659/AJCR.941424
Am J Case Rep 2023; 24:e941424
18 Feb 2024 : Case report
21,974
DOI :10.12659/AJCR.943030
Am J Case Rep 2024; 25:e943030